Company Filing History:
Years Active: 2025
Title: Remi Fertin: Innovator in Antibody Development
Introduction
Remi Fertin is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules for therapeutic applications. With a total of 2 patents, his work focuses on innovative solutions for treating diseases, including cancer.
Latest Patents
Fertin's latest patents include groundbreaking inventions in the realm of antibody technology. One of his patents involves anti-mesothelin antibodies, which are designed to bind to mesothelin (MSLN). These antibody molecules have potential applications in the treatment and diagnosis of various diseases and disorders, particularly cancer. Another significant patent relates to antibody molecules that bind both mesothelin (MSLN) and CD137. This invention features a CDR-based binding site for MSLN and a CD137 antigen-binding site located in a constant domain of the antibody molecule, further enhancing its application in cancer treatment.
Career Highlights
Throughout his career, Remi Fertin has worked with prominent companies in the biotechnology sector. Notable among these are Invox Pharma Limited and F-star Therapeutics, Inc. His experience in these organizations has allowed him to refine his expertise in antibody development and therapeutic applications.
Collaborations
Fertin has collaborated with several professionals in his field, including Jose Munoz-Olaya and Mihriban Tuna. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Remi Fertin stands out as an innovative inventor in the biotechnology industry, with a focus on antibody development for cancer treatment. His contributions through his patents and collaborations highlight his commitment to advancing medical science.